RT Journal Article
SR Electronic
T1 Optimizing rabies vaccination of dogs in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.10.23288318
DO 10.1101/2023.04.10.23288318
A1 Cuddington, Kim
A1 McAuliffe, William H.B.
YR 2023
UL http://medrxiv.org/content/early/2023/04/20/2023.04.10.23288318.abstract
AB Dog vaccination is the key to controlling rabies in human populations. However, in countries like India, with large free-roaming dog populations, vaccination strategies that rely only on parenteral vaccines are unlikely to be either feasible or successful. Oral rabies vaccines could be used to reach these dogs. We use costs estimates for an Indian city and linear optimization to find the most cost-effective vaccination strategies. We show that an oral bait handout method for dogs that are never confined can reduce the per dog costs costs of vaccination, and increase vaccine coverage. This finding holds even when baits cost up to 10x the price of parenteral vaccines, if there is a large dog population or proportion of dogs that are never confined. We suggest that oral rabies vaccine baits will be part of the most cost-effective strategies to eradicate human deaths from dog-mediated rabies by 2030.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Rethink PrioritiesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis is a modelling study which has generated no data. Code is available at https://github.com/kcudding/rabies. https://github.com/kcudding/rabies